Given that PRMT5 is widely recognized as a crucial oncogene in various malignant cancers, including NSCLC [29–31], we investigated whether the EP300-AS1-PTBP1 axis could regulate PRMT5 expression in NSCLC cells. Here, EP300 is linked to non-small cell lung carcinoma.